Institute for Wealth Management LLC. grew its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 4.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,490 shares of the exchange traded fund’s stock after purchasing an additional 441 shares during the quarter. Institute for Wealth Management LLC.’s holdings in SPDR S&P Biotech ETF were worth $855,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in the business. Oak Harvest Investment Services purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $2,633,000. Calton & Associates Inc. purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $494,000. OLD National Bancorp IN purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $450,000. Highland Capital Management LLC increased its holdings in SPDR S&P Biotech ETF by 10.4% in the 4th quarter. Highland Capital Management LLC now owns 25,509 shares of the exchange traded fund’s stock worth $2,297,000 after acquiring an additional 2,404 shares during the last quarter. Finally, Ibex Wealth Advisors purchased a new stake in SPDR S&P Biotech ETF in the 4th quarter worth about $1,473,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI opened at $92.67 on Friday. The business has a 50-day moving average of $93.24 and a 200 day moving average of $96.72. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The firm has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Nebius Group: Market Overreaction or Real AI Disruption?
- Where to Find Earnings Call Transcripts
- The Best Way to Invest in Gold Is…
- Buy P&G Now, Before It Sets A New All-Time High
- Why Nike Stock Could Be 2025’s Top Comeback Play
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.